Septic shock: desperately seeking treatment (Q38135863)

29 August 2017

title

Septic shock: desperately seeking treatment (English)

1 reference

29 August 2017

0 references

1 reference

1

1 reference

29 August 2017

author name string

Jaye P F Chin-Dusting

series ordinal

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

1 January 2014

1 reference

29 August 2017

1 reference

29 August 2017

volume

126

1 reference

29 August 2017

issue

1

1 reference

29 August 2017

page(s)

31-39

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

29 August 2017

1 reference

Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Sepsis: rethinking the approach to clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Microvascular blood flow is altered in patients with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Drotrecogin alfa (activated) in adults with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Proinflammatory and anti-inflammatory cytokines in meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Cytokine Cascade in Sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Immunosuppression in patients who die of sepsis and multiple organ failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Mixed antagonist response and sepsis severity-dependent dysbalance of pro- and anti-inflammatory responses at the onset of postoperative sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Interleukin-10: new perspectives on an old cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Ensuring animal welfare while meeting scientific aims using a murine pneumonia model of septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Characterization and modulation of the immunosuppressive phase of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Preclinical models of shock and sepsis: what can they tell us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Cecal ligation and puncture: the gold standard model for polymicrobial sepsis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Genomic responses in mouse models poorly mimic human inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Animal models of sepsis: setting the stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

An improved clinically relevant sepsis model in the conscious rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

DHEA-dependent and organ-specific regulation of TNF-alpha mRNA expression in a murine polymicrobial sepsis and trauma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Experimentally approaching the ICU: monitoring outcome-based responses in the two-hit mouse model of posttraumatic sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

The renin angiotensin system as a risk factor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Inflammation and angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

AT2 receptors: functional relevance in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Angiotensin II AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

ANG II is involved in the LPS-induced production of proinflammatory cytokines in dehydrated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Angiotensin-converting enzyme 2 protects from severe acute lung failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Ventilator-induced inflammatory response in lipopolysaccharide-exposed rat lung is mediated by angiotensin-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

Multiplex cytokine profiling in patients with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120668

21 January 2018

Identifiers

DOI

10.1042/CS20120668

1 reference

release_b6h2ukkg55amtekgmzb34apjne

29 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b6h2ukkg55amtekgmzb34apjne

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference